AzTrials
AzTrials

Stress, PsychologicalMFN&SOCCOGNCT03035669

Effects of Mindfulness Training on Emotion Regulation and Social Cognition.

A study testing Mindfulness group and Reading group in people with Stress, Psychological and Emotional Stress, run by Humboldt-Universität zu Berlin at 1 site in Germany.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The present study will investigate the effects of a mindfulness training on emotion regulation and social cognition, using several psychological, behavioral, psychophysiological and neuroimaging methods. Read more about this study

Who is it for?
Ages 18 to 55 yearsHealthy volunteers can take part
What is being tested?
Mindfulness group and Reading group
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteGermany
Study dates
Nov 2016to Jun 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 55 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Healthy volunteers: Men or women
  • Right-handed
  • Normal or corrected-to-normal visión
  • German as a first language
  • No history of neurological or psychiatric problems, or use of controlled medication that might interfere with emotion or attention.
  • No symptoms of claustrophobia
  • Written informed consent form to participate in the study and neuro-imaging experiment.

Who cannot join

  • Chemical dependence, including nicotine and alcohol
  • Dementia or psychotic condition.
  • Depression or use of antidepressants
  • Pregnant or breast-feeding women
  • Prior MBSR class or regularly practicing mindfulness meditation (or yoga) for three or more months.
  • Non-controlled severe medical disease that might interfere with the performance of the study, such as neoplasias, cardiopathies, digestive pathologies, diabetes mellitus type I or type II
Show all 11Show fewer
  • Neoplasias in the central nervous system
  • Tremor or dystonia in cephalic segment that hinders the performance of the MRI study (tremor equal to or higher than 3 in each corporal segment, according to the UPDRS scale)
  • Fulfillment of any criterion of contraindication for the MRI exam (for instance, metallic implants, claustrophobia, pregnancy, use of pacemaker; intracranial aneurism clip; cochlear implants).
  • Presence of odontological devices that might disturb the magnetic field or any sources of variation of the magnetic susceptibility
  • Any other conditions the investigator might deem problematic for the inclusion of the volunteer in a trial of this nature will also be considered.

Trial locations and contacts

1 site in 1 country.

Isabel Dziobek, Professor, PhD. contact

(030) 2093-6186

isabel.dziobek@hu-berlin.de

Germany1 site, 1 recruiting
  • Berlin School of Mind & Brain, Humboldt Universität.

    Berlin, State of Berlin, 10117

    Simon Guendelman, MD, (030) 2093-6186, simon.guendelman@hu-berlin.de

    Recruiting

Other trials in Germany

About this study

Official title: Effects of Mindfulness Training on Emotion Regulation and Social Cognition, a Psychophysiological and Neuroimaging Randomized Controled Study.

The present study will investigate the effects of a mindfulness training on emotion regulation and social cognition, using several psychological, behavioral, psychophysiological and neuroimaging methods.

Read the detailed description

The aim of the present study is to evaluate the impact of a mindfulness intervention, particularly the mindfulness-based stress reduction (MBSR), on the capacities of emotion regulation and social cognition, in caring/helping professions which are vulnerable to stress. In the context of a longitudinal intervention study, a randomized controlled trial, the efficacy of the MBSR to increase the capacity for self-emotion regulation, empathic attunement, and compassion capacities will be measured. For doing this, several psychological, behavioral, psychophysiological and neuroimaging brain measurements will be used.

Being tested
Mindfulness group, Reading group
Medical subject headings
Stress, Psychological

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mindfulness groupBehavioural

    Also called mindfulness based stress reduction

    8 week program

  • Reading groupBehavioural

    Also called Reading and sharing group

    8 week program

Study groups in NCT03035669
Study groupRoleWhat they receive
Mindfulness groupExperimentalMindfulness based stress reduction: 8 week program, including meditation, body-awareness, and yoga practices. Daily assignments and home practices during 50 minutes per day.
Receives: Behavioral: Mindfulness group
Reading groupActive comparatorReading and sharing group: 8 week program, including readings, interpersonal exchanges, group discussion, listening and role playing exercises. Daily assignments and home practices during 50 minutes per day.
Receives: Behavioral: Reading group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Activation changes in emotions related brain regions. Measured by significant changes in the BOLD (blood oxygenated level dependent) signal from task based functional magnetic resonance imaging.

    Measured: first acquisition period during 3 weeks before the intervention, second acquisition period during 3 weeks after the intervention.

  2. Changes in resting state functional connectivity within brain networks. Measured by significant changes in intrinsic functional connectivity parameters, estimated from the resting state BOLD signal, during functional magnetic resonance imaging.

    Measured: first acquisition period during 3 weeks before the intervention, second acquisition period during 3 weeks after the intervention.

Secondary outcomes (10)
  1. Changes in resting state functional connectivity between inter-networks connectivity.

    Changes between brain networks connectivity (including DMN, fronto-parietal and salience networks), measured as significant changes in inter-networks connectivity parameters estimated from the temporal correlation of intrinsic functional connectivity networks.

    Measured: first acquisition period during 3 weeks before the intervention, second acquisition period during 3 weeks after the intervention.

  2. Changes in regional brain morphometry in stress processing related areas. Measured by significant changes in regional grey matter density estimated from structural magnetic resonance imaging.

    Measured: first acquisition period during 3 weeks before the intervention, second acquisition period during 3 weeks after the intervention.

  3. Behavioural tasks: mind-wandering task

    Changes in mind-wandering task, measured as changes in task-unrelated thoughts.

    Measured: first acquisition period during 3 weeks before the intervention, second acquisition period during 3 weeks after the intervention.

  4. Changes in personality functioning.

    Significant changes in levels of personality functioning measured by the operationalized psychodynamic diagnosis scale.

    Measured: first acquisition period during 3 weeks before the intervention, second acquisition period during 3 weeks after the intervention.

  5. Experience Sampling of emotional tolerance

    Significant changes in self-reported capacity for emotion tolerance.

    Measured: first acquisition period during 3 weeks before the intervention, last acquisition period during 3 weeks after the intervention. And during the intervention period everyday.

  6. Changes in psychophysiological measurements of stress (sympathetic component)

    Activation changes in psychophysiological stress parameters using Skin Conductance Response (measured as significant changes in tonic and phasic response levels) during an emotion regulation task.

    Measured: first acquisition period during 3 weeks before the intervention, second acquisition period during 3 weeks after the intervention.

  7. Changes in psychophysiological measurements of stress (vagal component)

    Activation changes in psychophysiological stress parameters using Heart Rate Variability (power analysis of high frequency sub-bands of heart rate spectrum), during an emotion regulation task.

    Measured: first acquisition period during 3 weeks before the intervention, second acquisition period during 3 weeks after the intervention.

  8. Behavioural tasks: empathy test.

    Changes in empathy test, measured as changes in levels of cognitive and affective empathy.

    Measured: first acquisition period during 3 weeks before the intervention, second acquisition period during 3 weeks after the intervention.

  9. Changes in self-reported affective states

    Significant changes in self-reported levels of negative and positive affects measured by the PANAS scale.

    Measured: first acquisition period during 3 weeks before the intervention, second acquisition period during 3 weeks after the intervention.

  10. Changes in social functioning

    Significant changes in the interpersonal competence questionnaire self-reported scale.

    Measured: first acquisition period during 3 weeks before the intervention, second acquisition period during 3 weeks after the intervention.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Jan 2017 (estimated)
  2. Study startNov 2016
  3. Primary completionJun 2017 (estimated)
  4. Study completionJun 2017 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03035669
Sponsor's protocol ID
HumboldtUB
Acronym
MFN&SOCCOG
Status last verified
Jan 2017
First submitted
30 Nov 2016
Last updated
30 Jan 2017
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Publications

  • Guendelman S, Bayer M, Prehn K, Dziobek I. Towards a mechanistic understanding of mindfulness-based stress reduction (MBSR) using an RCT neuroimaging approach: Effects on regulating own stress in social and non-social situations. Neuroimage. 2022 Jul 1;254:119059. doi: 10.1016/j.neuroimage.2022.119059. Epub 2022 Mar 5.

    PubMed 35259523

Questions about this trial

What is this clinical trial studying?

A study testing Mindfulness group and Reading group in people with Stress, Psychological and Emotional Stress, run by Humboldt-Universität zu Berlin at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 30 Jan 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Isabel Dziobek, Professor, PhD. ((030) 2093-6186, isabel.dziobek@hu-berlin.de), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Activation changes in emotions related brain regions. Measured by significant changes in the BOLD (blood oxygenated level dependent) signal from task based functional magnetic resonance imaging. (time frame: first acquisition period during 3 weeks before the intervention, second acquisition period during 3 weeks after the intervention.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03035669, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Jan 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in